Search
for
Sort by
Research 901–930 of 1000+
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Indications for Peripheral and Central Sensitization in Patients With Chronic Scalp Pain (Trichodynia)
- Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?
- Stem cell apoptosis in HIV‐1 alopecia
- Metabolic Syndrome and Insulin Resistance Syndrome among Infertile Women with Polycystic Ovary Syndrome: A Cross-Sectional Study from Central Vietnam
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Preferential Recognition of Hydroxyl Radical-Modified Superoxide Dismutase by Circulating Autoantibodies in Patients with Alopecia Areata
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Enrichment and Characterization of Human Dermal Stem/Progenitor Cells by Intracellular Granularity
- Serum irisin: A prognostic marker for severe acne vulgaris
- Proton Affinitive Derivatization for Highly Sensitive Determination of Testosterone and Dihydrotestosterone in Saliva Samples by LC-ESI-MS/MS
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- Genomic and transcriptomic landscape to decipher the genetic basis of hyperpigmentation in Lanping black-boned sheep (Ovis aries)
- Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology
- PREVALENCE OF PERIODONTAL DISEASE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME- A COMPARATIVE DESCRIPTIVE STUDY
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Serum 1, 25-dihydroxy vitamin D- vitamin D3- among obese Egyptian women with polycystic ovary syndrome
- New Criteria for the Clinical Diagnosis of Hyperandrogenism in Polycystic Ovarian Syndrome and the Risk of Overdiagnosis
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Identification of the Novel Membrane-Associated Protein AgK114 on Hamster Keratinocytes Recognized by a Monoclonal Antibody K114
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Study of Cutaneous Manifestations of Polycystic Ovarian Syndrome
- Serum ferritin levels in non-scarring alopecia of women: a case-control study
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- Phenotypic Heterogeneity in 5 Japanese Patients with an Identical Point Mutation in the Vitamin D Receptor Gene
- Obesity and hyperandrogenism are implicated with anxiety, depression and food cravings in women with polycystic ovary syndrome.